{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:04:49Z","timestamp":1790424289810,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"The Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["MOST 106-2314-B-303 -003"],"award-info":[{"award-number":["MOST 106-2314-B-303 -003"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"The Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["MOST 105-2314-B-303-020-MY2"],"award-info":[{"award-number":["MOST 105-2314-B-303-020-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Buddhist Tzu Chi Medical Foundation, Taiwan","award":["Tzu Chi Medical Mission Project 105-01-02,"],"award-info":[{"award-number":["Tzu Chi Medical Mission Project 105-01-02,"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1754-1","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T04:33:48Z","timestamp":1542774828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Aberrant expression of interleukin-23-regulated miRNAs in T cells from patients with ankylosing spondylitis"],"prefix":"10.1186","volume":"20","author":[{"given":"Ning-Sheng","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hsueh","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Yung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-0351","authenticated-orcid":false,"given":"Ming-Chi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"1754_CR1","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis. 2011;70:1921\u20135.","journal-title":"Ann Rheum Dis"},{"key":"1754_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390:73\u201384.","journal-title":"Lancet"},{"key":"1754_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","volume":"13","author":"V Ranganathan","year":"2017","unstructured":"Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N. Pathogenesis of ankylosing spondylitis - recent advances and future directions. Nat Rev Rheumatol. 2017;13:359\u201367.","journal-title":"Nat Rev Rheumatol"},{"key":"1754_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","volume":"1","author":"DA Brewerton","year":"1973","unstructured":"Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet. 1973;1:904\u20137.","journal-title":"Lancet"},{"key":"1754_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/ng.2007.17","volume":"39","author":"PR Burton","year":"2007","unstructured":"Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC), Burton PR, Clayton DG, Cardon LR, Craddock N, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39:1329\u201337.","journal-title":"Nat Genet"},{"key":"1754_CR6","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1159\/000480211","volume":"42","author":"Y Wang","year":"2017","unstructured":"Wang Y, Luo J, Wang X, Yang B, Cui L. MicroRNA-199a-5p induced autophagy and inhibits the pathogenesis of ankylosing spondylitis by modulating the mTOR signaling via directly targeting Ras homolog enriched in brain (Rheb). Cell Physiol Biochem. 2017;42:2481\u201391.","journal-title":"Cell Physiol Biochem"},{"key":"1754_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/art.38291","volume":"66","author":"JA Smith","year":"2014","unstructured":"Smith JA, Colbert RA. The interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond. Arthritis Rheumatol. 2014;66:231\u201341.","journal-title":"Arthritis Rheumatol"},{"key":"1754_CR8","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, et al. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. N Engl J Med. 2015;373:2534\u201348.","journal-title":"N Engl J Med"},{"key":"1754_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cei.12089","volume":"173","author":"NS Lai","year":"2013","unstructured":"Lai NS, Yu HC, Chen HC, Yu CL, Huang HB, Lu MC. Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin Exp Immunol. 2013;173:47\u201357.","journal-title":"Clin Exp Immunol"},{"key":"1754_CR10","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1002\/jcp.26500","volume":"233","author":"H Mohammadi","year":"2018","unstructured":"Mohammadi H, Hemmatzadeh M, Babaie F, Gowhari Shabgah A, Azizi G, Hosseini F, et al. MicroRNA implications in the etiopathogenesis of ankylosing spondylitis. J Cell Physiol. 2018;233:5564\u201373.","journal-title":"J Cell Physiol"},{"key":"1754_CR11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/annrheumdis-2016-210175","volume":"76","author":"L Chen","year":"2017","unstructured":"Chen L, Al-Mossawi MH, Ridley A, Sekine T, Hammitzsch A, de Wit J, et al. miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis. Ann Rheum Dis. 2017;76:620\u20135.","journal-title":"Ann Rheum Dis"},{"key":"1754_CR12","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.4049\/jimmunol.1000917","volume":"186","author":"Z Li","year":"2011","unstructured":"Li Z, Wu F, Brant SR, Kwon JH. IL-23 receptor regulation by Let-7f in human CD4+ memory T cells. J Immunol. 2011;186:6182\u201390.","journal-title":"J Immunol"},{"key":"1754_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715\u201325.","journal-title":"Immunity"},{"key":"1754_CR14","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1002\/eji.200939759","volume":"40","author":"AN Sieve","year":"2010","unstructured":"Sieve AN, Meeks KD, Lee S, Berg RE. A novel immunoregulatory function for IL-23: inhibition of IL-12-dependent IFN-\u03b3 production. Eur J Immunol. 2010;40:2236\u201347.","journal-title":"Eur J Immunol"},{"key":"1754_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/ard.2009.108217","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Landew\u00e9 R, van der Heijde D, Listing J, Brandt J, Braun J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68:770\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1754_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13075-017-1465-z","volume":"19","author":"NS Lai","year":"2017","unstructured":"Lai NS, Yu HC, Tung CH, Huang KY, Huang HB, Lu MC. The role of aberrant expression of T cell miRNAs affected by TNF-\u03b1 in the immunopathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017;19:261.","journal-title":"Arthritis Res Ther"},{"key":"1754_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D van der Heijde","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68:1811\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1754_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2249.2012.04676.x","volume":"171","author":"MC Lu","year":"2013","unstructured":"Lu MC, Lai NS, Chen HC, Yu HC, Huang KY, Tung CH, et al. Decreased microRNA (miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin Exp Immunol. 2013;171:91\u20139.","journal-title":"Clin Exp Immunol"},{"key":"1754_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012;7:562\u201378.","journal-title":"Nat Protoc"},{"key":"1754_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000445834","volume":"169","author":"Y Li","year":"2016","unstructured":"Li Y, Wang H, Lu H, Hua S. Regulation of memory T cells by interleukin-23. Int Arch Allergy Immunol. 2016;169:157\u201362.","journal-title":"Int Arch Allergy Immunol"},{"key":"1754_CR21","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/eji.201242598","volume":"42","author":"AL Croxford","year":"2012","unstructured":"Croxford AL, Mair F, Becher B. IL-23: one cytokine in control of autoimmunity. Eur J Immunol. 2012;42:2263\u201373.","journal-title":"Eur J Immunol"},{"key":"1754_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/rheumatology\/kew336","volume":"56","author":"W Nakayama","year":"2017","unstructured":"Nakayama W, Jinnin M, Tomizawa Y, Nakamura K, Kudo H, Inoue K, et al. Dysregulated interleukin-23 signalling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression. Rheumatology (Oxford). 2017;56:145\u201355.","journal-title":"Rheumatology (Oxford)"},{"key":"1754_CR23","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1182\/blood-2009-10-248245","volume":"116","author":"C Cocco","year":"2010","unstructured":"Cocco C, Canale S, Frasson C, Di Carlo E, Ognio E, Ribatti D, et al. Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. Blood. 2010;116:3887\u201398.","journal-title":"Blood"},{"key":"1754_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13059-016-0901-8","volume":"17","author":"H Wang","year":"2016","unstructured":"Wang H, Chao K, Ng SC, Bai AH, Yu Q, Yu J, et al. Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease. Genome Biol. 2016;17:58.","journal-title":"Genome Biol"},{"key":"1754_CR25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.bbrc.2014.10.002","volume":"453","author":"C Hou","year":"2014","unstructured":"Hou C, Zhu M, Sun M, Lin Y. MicroRNA let-7i induced autophagy to protect T cell from apoptosis by targeting IGF1R. Biochem Biophys Res Commun. 2014;453:728\u201334.","journal-title":"Biochem Biophys Res Commun"},{"key":"1754_CR26","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1515\/cclm-2015-1108","volume":"55","author":"X Shen","year":"2017","unstructured":"Shen X, Ye Y, Qi J, Wu X, Ni H, Cong H, et al. Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma. Clin Chem Lab Med. 2017;55:748\u201354.","journal-title":"Clin Chem Lab Med"},{"key":"1754_CR27","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1158\/1078-0432.CCR-11-1724","volume":"17","author":"N Giuliani","year":"2011","unstructured":"Giuliani N, Airoldi I. Novel insights into the role of interleukin-27 and interleukin-23 in human malignant and normal plasma cells. Clin Cancer Res. 2011;17:6963\u201370.","journal-title":"Clin Cancer Res"},{"key":"1754_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-016-0949-6","volume":"18","author":"FM Milanez","year":"2016","unstructured":"Milanez FM, Saad CG, Viana VT, Moraes JC, P\u00e9rico GV, Sampaio-Barros PD, et al. IL-23\/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients. Arthritis Res Ther. 2016;18:52.","journal-title":"Arthritis Res Ther"},{"key":"1754_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-3083.2009.02361.x","volume":"71","author":"A Paradowska-Gorycka","year":"2010","unstructured":"Paradowska-Gorycka A, Grzybowska-Kowalczyk A, Wojtecka-Lukasik E, Maslinski S. IL-23 in the pathogenesis of rheumatoid arthritis. Scand J Immunol. 2010;71:134\u201345.","journal-title":"Scand J Immunol"},{"key":"1754_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/15476286.2016.1272746","volume":"14","author":"SM Lyons","year":"2017","unstructured":"Lyons SM, Fay MM, Akiyama Y, Anderson PJ, Ivanov P. RNA biology of angiogenin: current state and perspectives. RNA Biol. 2017;14:171\u20138.","journal-title":"RNA Biol"},{"key":"1754_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/abbs\/gmv131","volume":"48","author":"J Sheng","year":"2016","unstructured":"Sheng J, Xu Z. Three decades of research on angiogenin: a review and perspective. Acta Biochim Biophys Sin Shanghai. 2016;48:399\u2013410.","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"key":"1754_CR32","first-page":"861435","volume":"2014","author":"SH Lee","year":"2014","unstructured":"Lee SH, Kim KW, Min KM, Kim KW, Chang SI, Kim JC. Angiogenin reduces immune inflammation via inhibition of TANK-binding kinase 1 expression in human corneal fibroblast cells. Mediators Inflamm. 2014;2014:861435.","journal-title":"Mediators Inflamm"},{"key":"1754_CR33","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s10753-013-9609-z","volume":"36","author":"H Hayashi","year":"2013","unstructured":"Hayashi H, Kawakita A, Okazaki S, Yasutomi M, Murai H, Ohshima Y. IL-17A\/F modulates fibrocyte functions in cooperation with CD40-mediated signaling. Inflammation. 2013;36:830\u20138.","journal-title":"Inflammation"},{"key":"1754_CR34","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.3892\/etm.2016.3786","volume":"12","author":"T Eleftheriadis","year":"2016","unstructured":"Eleftheriadis T, Pissas G, Sounidaki M, Antoniadis N, Antoniadi G, Liakopoulos V, et al. Angiogenin is upregulated during the alloreactive immune response and has no effect on the T-cell expansion phase, whereas it affects the contraction phase by inhibiting CD4+ T-cell apoptosis. Exp Ther Med. 2016;12:3471\u20135.","journal-title":"Exp Ther Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1754-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1754-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1754-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T19:19:27Z","timestamp":1574277567000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1754-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1754"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1754-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"4 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the institutional review board of Buddhist Dalin Tzu Chi Hospital, Taiwan (no. B10502002). Signed informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"259"}}